XML 37 R21.htm IDEA: XBRL DOCUMENT
v3.20.1

Condensed Parent Company Only Financial Statement | 12 Months Ended
--- | ---
Dec. 31, 2019
Parent Company Only Financial Statement |
CONDENSED PARENT COMPANY ONLY FINANCIAL STATEMENT | Note 15 - Condensed parent company only financial statement The condensed parent company only financial information for China Pharma Holdings Inc. is presented below:
Condensed Comparative Balance Sheets |  |  |  |  |
|  | December 31, |
|  | 2019 |  |  | 2018 |
Cash and cash equivalents |  | $ | 3,095 |  |  | $ | 5,170 |
Total Current Assets |  |  | 3,095 |  |  |  | 5,170 |
Intercompany receivables |  |  | 8,084,779 |  |  |  | 8,384,779 |
Investment in subsidiary |  |  | 11,705,241 |  |  |  | 11,705,241 |
TOTAL ASSETS |  | $ | 19,793,115 |  |  | $ | 20,095,190 |
Total liabilities - other payables |  | $ | 2,401,344 |  |  | $ | 2,181,033 |
Total Stockholders' Equity |  |  | 17,391,771 |  |  |  | 17,914,157 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |  | $ | 19,793,115 |  |  | $ | 20,095,190 |
The parent company had no contingencies, long-term obligations and guarantees as of December 31, 2019 and 2018.
Condensed Comparative Statements of Operations
|  | For the Years |
|  | Ended December 31, |
|  | 2019 |  |  | 2018 |
General and administrative expenses |  | $ | 522,386 |  |  | $ | 525,151 |
Net loss |  | $ | (522,386 | ) |  | $ | (525,151 | )
Condensed Comparative Statements of Cash Flows |  |  |  |  |
|  | For the Years |
|  | Ended December 31, |
|  | 2019 |  |  | 2018 |
Cash Flows from Operating Activities: |  |  |  |  |  |  |  |
Net loss |  | $ | (522,386 | ) |  | $ | (525,151 | )
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Total liabilities |  |  | 220,311 |  |  |  | 259,600 |
Net Cash Used in Operating Activities |  |  | (302,075 | ) |  |  | (265,551 | )
Net Cash Used in Investing Activities |  |  | - |  |  |  | - |
Cash Flows from Financing Activities: |  |  |  |  |  |  |  |
Change in intercompany receivables |  |  | 300,000 |  |  |  | 193,000 |
Net Cash Used in Financing Activities |  |  | 300,000 |  |  |  | 193,000 |
Net Decrease in Cash and Cash Equivalents |  |  | (2,075 | ) |  |  | (72,551 | )
Cash and Cash Equivalents at Beginning of Period |  |  | 5,170 |  |  |  | 77,722 |
Cash and Cash Equivalents at End of Period |  | $ | 3,095 |  |  | $ | 5,171 |

X
- References No definition available. + Details
Name: | cphi_CondensedParentCompanyOnlyFinancialStatementAbstract
Namespace Prefix: | cphi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=108774443&loc=d3e5283-111683 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration